Combined treatment of PA and LPS in RAW264.7 cells mimics the situation of diabetes with obesity that has higher level of PA and LPS, MAPK/TLR4/ MCP-1 might be potential therapeutic targets for diabetes with obesity. This evidence concerns the gene CCL2 and obesity due to melanocortin 4 receptor deficiency.